Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea Pollen

NCT00831025 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis or Rhinoconjunctivitis With or Without Asthma Induced by Hypersensitivity to Olea Europea Pollen

Interventions

BIOLOGICAL: Immunotherapy with modified extract of Olea europaea pollen
BIOLOGICAL: Placebo

Sponsor

Laboratorios Leti, S.L.